In order to build upon Medicollect’s great relations with site personnel, Medicollect has decided to hire two dedicated Site Relations Managers, responsible for communication with research nurses and investigators at sites in Denmark and United Kingdom.
“For quite a while, we have been looking for people with strong communication skills, thorough understanding of the challenges faced by site personnel, and an empathetic personality. I am happy to say that we have succeeded”, says Medicollect’s CEO, Rene Vind Ludwigs.
The British Site Relations Manager, Cassie Merenick is an experienced nurse with several health care competencies from both Canada and Sweden. She has been involved with research projects throughout her career. She has extensive knowledge about the work day as a nurse and insights on strongholds, and the challenges site personnel face.
“I know how difficult it is to find the patients needed for modern clinical trials. Protocols are becoming increasingly specific, with narrowing participation criteria. This, in turn, leads to greater patient recruitment challenges. Finding the time and resources to recruit patients is becoming a heavier burden for site personnel”, Cassie Merenick explains.
And she continues:
“This position as Site Relations Manager, is like a dream come true professionally. I have always wanted to combine my competencies within clinical research while meeting patient’s needs. At Medicollect I have the opportunity to achieve this rare and unique combination. It makes me very proud and enthusiastic”.
Want to know more about Medicollect’s focus on site relations?
Contact Torben LInd at firstname.lastname@example.org
Facts on Medicollect
- Patient Recruitment Organisation (PRO) since 2012
- Recruiting patients in Europe across all diseases
Following the vendor qualification in July, SANOFI rushed to place not just one but two orders with Medicollect.
In line with Medicollect’s core competence, the company will assist SANOFI with recruiting people with diabetes for 2 clinical trials in UK.
Rene Ludwigs, CEO in Medicollect, is particular proud of these projects: “SANOFI is the worlds second largest producer of diabetes medicines.
So to have them requesting our services is a true seal of approval to us. We are of course proud that global pharmaceutical companies find our patient recruitment services is the best solution in the market”.
Want to know more?
Since 2014, Medicollect has been working with the worlds largest pharmaceutical companies, helping them recruit patients for their clinical trials.
As projects scale up, the time has come to focus on vendor qualifications. Until recently, both Novartis and MSD have completed these extensive qualification procedures and approved the Medicollect set-up.
SANOFI is the latest, scrutinizing all SOP’s submitted by Medicollect for vendor qualification, making it the third finalized procedure from a global pharmaceutical company.
As Rene Ludwigs, CEO of Medicollect, phrases it, “We are, of course, proud that global pharmaceutical companies are eager to enter into vendor partnerships with Medicollect. We focus exclusively on solving the recruitment challenges faced by companies involved with clinical trials and our services put forth the best solution the market has to offer right now”.
Want to know more?